Binding of the eukaryotic translation elongation factor 1A with the 5’UTR of HIV-1 genomic RNA is important for reverse transcription by Dongsheng Li et al.
Li et al. Virology Journal  (2015) 12:118 
DOI 10.1186/s12985-015-0337-xRESEARCH Open AccessBinding of the eukaryotic translation
elongation factor 1A with the 5’UTR of HIV-1
genomic RNA is important for reverse transcription
Dongsheng Li1, Ting Wei1, Hongping Jin1, Amanda Rose1, Rui Wang1,3, Min-Hsuan Lin1, Kirsten Spann2
and David Harrich1*Abstract
Background: The cellular protein eukaryotic translation elongation factor 1A (eEF1A) binds to aminoacylated
transfer RNAs and delivers them to the ribosome during translation. eEF1A also binds to RNA secondary structures
present in genomes of several RNA viruses and plays important roles in their replication. As a RNA binding protein,
whether eEF1A can bind with HIV-1 genomic RNA has not been investigated and was the aim of the study.
Methods: RNA-protein interaction was determined by reversible crosslink co-immunoprecipitation (RC-Co-IP) and
biolayer Interferometry assay (BLI). eEF1A binding region within RNA was mapped by deletion and mutation
analysis. Virus with genomic RNA mutations were examined for eEF1A-RT interaction by proximity ligation assay, for
reverse transcription by qPCR and for replication by CAp24 ELISA in cells.
Results: The interaction of eEF1A with 5’UTR of HIV-1 genomic RNA was detected in cells and in vitro. Truncation
and substitution mutations in the 5’UTR RNA demonstrated that a stem-loop formed by nucleotides 142 to 170,
which encompass a reported tRNA anticodon-like-element, binds to eEF1A. Mutations that altered the stem-loop
structure by changing two highly conserved sequence clusters in the stem-loop region result in reduction of the
interaction with eEF1A in vitro. HIV-1 virus harbouring the same 5’UTR mutations significantly reduced the interaction of
eEF1A with HIV-1 reverse transcription complex (RTC), reverse transcription and replication.
Conclusion: eEF1A interacts with 5’UTR of HIV-1 genomic RNA and the interaction is important for late DNA synthesis
in reverse transcription.
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The eukaryotic translation elongation factor 1A (eEF1A)
is a subunit of the eukaryotic translation elongation 1
complex (eEF1) and its canonical role in translational
elongation is to bind and deliver aminoacylated transfer
RNAs (aa-tRNAs) to the elongating ribosome. eEF1A is
reported to have many moonlighting activities including
roles as a protein chaperone, in RNA and actin-binding,
protein degradation, nucleocytoplasmic trafficking and
multiple aspects of cytoskeletal regulation [1, 2]. There is
increasing evidence showing that eEF1A plays a diverse* Correspondence: david.harrich@qimrberghofer.edu.au
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through the interaction with viral genomic RNA, viral
proteins and cellular proteins [1, 3–6].
Previously studies showed that cellular factors are im-
portant for efficient HIV-1 reverse transcription [7–11].
Our recent study demonstrated that eEF1A associates
with the HIV-1 reverse transcription complex (RTC) and
plays an important role in HIV-1 reverse transcription
[12]. In newly infected cells where eEF1A is downregu-
lated by transfecting siRNAs, the stability of the viral
RTC is greatly decreased, which results in sharply re-
duced levels of reverse transcription late DNA product
[12]. On the other hand, a reported protein: protein
interaction between eEF1A and HIV-1 Gag required
RNA as a cofactor [13], which was important for viriontributed under the terms of the Creative Commons Attribution 4.0 International
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
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interact with HIV-1 genomic RNA, as it does with other
RNA viruses, in order to facilitate association with the
HIV-1 RTC has not been investigated.
The HIV-1 genomic RNA 5’UTR has features that
could support eEF1A binding as it contains many RNA
stem-loop structures and elements including; i) the pri-
mer binding site (PBS) which serves as the binding site
for cellular tRNAlys [14], and ii) a recently identified
tRNA anti-codon-like element (TLE) located proximal
to the PBS [15, 16], which can specifically bind to
human lysyl-tRNA synthetase [15] and iii) a series of
stem-loop structures that regulate polyadenylation, RNA
packaging, and RNA dimerization [17]. By using revers-
ible crosslink co-immunoprecipitation (RC-co-IP) and
biolayer interferometry (BLI) assay, here we demon-
strated that eEF1A binds to the 5’UTR of HIV-1 gen-
omic RNA, and that the binding region within the RNA
is located between nucleotides (nt) 106 to 224. Muta-
tions of two highly conserved nucleotide clusters within
this RNA sequence, which are predicted to form alter-
native stem-loop structures, resulted in reduced associ-
ation of 5’UTR RNA with eEF1A and define nt 142 to
170 as important for interaction with eEF1A. HIV-1
with the same 5’UTR mutations showed a reduced asso-
ciation of eEF1A with reverse transcriptase, inefficient
reverse transcription and defective replication in cells.
We propose that eEF1A’s role in reverse transcription
requires interaction with a conserved stem-loop struc-
ture in U5.
Results
HIV-1 genomic RNA binds to eEF1A in infected cells
To examine whether eEF1A interacts with HIV-1 gen-
omic RNA, RC-co-IP experiment was performed in
HIV-1 infected TMZ-bl cells using an anti-eEF1A
antibody in the presence /absence of an HIV-1 reverse
transcriptase inhibitor, nevirapine. Nevirapine is a non-
nucleoside RT inhibitor of enzymatic activity. The RNA
was extracted from the IP products followed by RT-PCR
to examine the levels of HIV-1 RNA. A PCR without re-
verse transcription reaction was performed as a control
to detect DNA contamination. There was a large amount
of HIV-1 RNA detected in samples from HIV-1 infected
cells compared to infection with heat-inactivated virus
(p < 0.05), which are defective for viral entry, indicating
that HIV-1 RNA co-immunoprecipitated with eEF1A
(Fig. 1a). Similar levels of RNA were detected from the
infected cells incubated with nevirapine, suggesting that
the association of HIV-1 RNA with eEF1A is not
dependent on RT activity. Samples analyzed by qPCR,
which omit the cDNA synthesis step, showed low levels of
viral DNA that were similar to the heat-inactivated sam-
ples indicating that the RNA samples were not DNAcontaminations (Fig. 1a). Importantly, RC-co-IP using a
control antibody anti-eIF3A (Fig. 1a), did not specifically
capture HIV-1 RNA suggesting that the interaction be-
tween eEF1A and HIV-1 RNA in cells was specific.
eEF1A directly binds to the 5’UTR of HIV-1 RNA
The association of eEF1A and HIV-1 genomic RNA de-
tected from infected cells could be due to indirect bind-
ing through virus proteins. To determine whether
eEF1A specifically binds HIV-1 RNA in the absence of
the viral proteins, equivalent amounts of biotin-labeled
RNAs corresponding to the 5’UTR (the 5’UTR RNA
used corresponded to nucleotides 1 to 325 of the HIV
RNA genome), a similarly sized RNA from the RT en-
coding region (RT RNA) or a biotin-labelled luciferase
RNA were transfected individually into TZM-bl cells
followed by a RC-co-IP assay using an anti-eEF1A anti-
body. The RNA extracted from the IP products were
subjected to a dot blot for biotin labelled RNA detection.
As shown in Fig. 1b (upper panel), the RNAs extracted
from each lysate contained a similar level of biotin la-
belled RNA. However a measurably larger amount
5’UTR RNA was recovered from anti-eEF1A co-IP prod-
uct than RT or luciferase RNAs (Fig. 1b, lower panel
and Fig. 1c). The result suggests that 5’UTR RNA inter-
acts with eEF1A in the absence of viral protein.
5’UTR RNA binds to eEF1A in biolayer Interferometry (BLI)
assay
While co-IP assays can detect associations between mol-
ecules, they cannot determine if an association between
molecules occurs by direct or indirect binding. To deter-
mine if 5’UTR RNA has a direct interaction with eEF1A
without any other cellular protein, an in vitro BLI assays
was employed using purified protein. The BLI method
uses the interference pattern of white light reflected
from two surfaces on a biosensor probe: a layer of
immobilized molecule of interest, such as an RNA or
protein, and an internal reference layer. When the bio-
sensor is immersed in a solution containing a molecule
of interest, any change in the number of molecules
bound to the biosensor tip due to interaction causes a
shift in the interference pattern that can be measured.
Streptavidin-coated biosensors were saturated with
biotin-labelled 5’UTR, RT or luciferase RNAs individu-
ally. The association of each RNA with eEF1A was ex-
amined using the OctetRed system by incubating each
biosensor into kinetic buffer containing 90 nM and 30
nM of eEF1A. The 5’UTR RNA strongly bound with
eEF1A at 90 nM (Fig. 1d), while RT RNA showed a weak
binding (Fig. 1e), and no binding was detected with lu-
ciferase RNA (Fig. 1f ). Previously we showed that both
eEF1A and eEF1G associated with the HIV-1 RTC [12].
However using BLI assay, no binding was detected
Fig. 1 (See legend on next page.)
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Fig. 1 eEF1A binds to HIV-1 genomic RNA. a TMZ-bl cells were incubated with HIV-1 for 2 h at 4 °C and 2 h at 37 °C in the presence or absence
of nevirapine followed by RC-co-IP using anti-eEF1A or anti-eIF3A antibodies as indicated. The level of RNA extracted from IP product was
measured by RT-PCR targeting HIV-1 5’UTR. Data are presented as means ± SD from 3 independent experiments. TMZ-bl cells were also
transfected with biotin-labeled RNAs derived from HIV-1 genomic 5’UTR, HIV-1 RT and luciferase sequences followed by RC-co-IP. The RNAs in cell
lysates and recovered from IP using anti-biotin antibody (b, upper panel) or anti-eEF1A antibody (b, lower panel) were detected by dot blot using
streptavidin-peroxidase. The blot signals were quantified using ImageQuant programme and the relative PI unit of IP product to lysate product
are presented in c. The biotin-labelled d 5’UTR, e RT or f luciferase RNAs were immobilized on the biosensors coupling with streptavidin. The asso-
ciations of RNAs with eEF1A were measured with OctetRed system using 90nM or 30nM purified eEF1A protein and referenced using
90 nM of BSA in kinetic buffer. The dissociation was measured by moving the biosensor to wells containing kinetic buffer only. g The association
and dissociation of immobilized 5’UTR, RT and luciferase RNA with 90 nM of eEF1G was also measured as a control. Data are representative of 3
independent experiments. * indicates p < 0.05
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(Fig. 1g), indicating that the association between
5’UTR RNA and eEF1A is specific. The results are con-
sistent with the RC-co-IP results and confirm a direct
and specific interaction between 5’UTR of HIV-1 gen-
omic RNA and eEF1A.
The nt 106 to 224 of 5’UTR RNA is important for
interaction with eEF1A
5’UTR of HIV-1 genomic RNA contains several well-
defined RNA elements with important roles in HIV-1
replication. These elements include TAR, PolyA loop,
TLE, PBS, and the stem-loops 1 to 3 (SL1 to SL3) (Fig. 2a)
[15, 18]. To better define the eEF1A binding region in the
5’UTR RNA, two truncations of the 5’ UTR RNAs were
synthesized. The first truncation was made by removing
the stem-loops SL1-SL3 (designated 5’UTR-ΔSL1-3).
The second RNA contained only TAR and polyA re-
gions (designated TAR + polyA). The interaction of the
truncated 5’UTR RNAs, 5’UTR-ΔSL1-3 and TAR +
polyA with eEF1A were examined using BLI assay by
immobilizing biotinylated RNAs onto biosensors as de-
scribed earlier. The 5’UTR-ΔSL1-3 RNA showed a simi-
lar binding profile with eEF1A as the intact 5’UTR
RNA, and the maximum responses (nm) of the inter-
action with 90 nM eEF1A is 0.32 nm (no significant dif-
ference compared to the intact 5’UTR), whilst the
interaction of TAR + polyA with eEF1A was significantly
reduced (p < 0.05) (Fig. 2b). The results suggest that
RNA sequences after polyA and before SL1-3, which in-
cludes the TLE and PBS (nt 106 to 224), are important
for optimal interaction with eEF1A.
Alterations of the stem-loop structure that contains TLE
in 5’UTR RNA impair eEF1A binding
The region of the viral genome from nt 106 to 224 con-
tains a highly conserved RNA stem-loop structure [17],
which contains a TLE [15]. To examine whether this
RNA stem-loop is important for the interaction with
eEF1A, two mutants of 5’UTR were made in two highly
conserved sequence clusters [19, 20]. One mutant was
created by changing CCC of nt 142 to 144 in the bulgeregion to GGG (designated Bulge-M) and another mu-
tant was generated by changing CCC of nt 150 to 152
in the loop region to GGG (designated Loop-M)
(Fig. 2a). RNA-folding analysis shows that introductions
of these mutations alter the local RNA structures
formed by nt 142 to 170 (Fig. 2c) [21]. BLI assay were
performed to examine binding of the mutated 5’UTR
RNAs with eEF1A protein as described above. The
binding of the two mutant 5’UTR RNAs with eEF1A
were significant reduced compared to wild-type RNA
(p < 0.05) (Fig. 2b), indicating that the RNA stem-loop
structure formed by nt 142 to 170 are important for
binding by eEF1A.
Association of eEF1A with reverse transcriptase was
reduced in cells infected with viruses that contain the
bulge and loop mutations
The Bulge-M and Loop-M mutations were introduced
into a HIV-1 proviral plasmid DNA and the virus was
made by plasmid transfection into HEK293T cells. An
equivalent amount of each mutant and wild-type virus,
normalised to CAp24 levels, was used to infect TZM-bl
cells. Association of eEF1A with HIV-1 RT, a surrogate
marker of HIV-1 reverse transcription complex (RTC),
was determined by PLA at 2 h post-infection. PLA is a
modified fluorescent in situ hybridization method to de-
tect protein-protein interactions that produces fluores-
cent foci if the two PLA antibodies are in proximity.
Heat-inactivated virus, which is defective for viral entry,
was used to measure non-specific foci made by the PLA
antibodies. There was a significant reduction in the
number of foci present in cells infected with the mutant
compared to wild type virus (P < 0.01), while inactivated
wild type, which are defective for viral entry, virus pro-
duced very few foci (Fig. 3a). The levels of virus entry
into cells, as determined by measurement of genomic
RNA in the cytoplasm at 2 h of post-infection, were
similar indicating that reduced levels of eEF1A-RTC asso-
ciation in mutated virus infection were not due to differ-
ences in viral entry (Fig. 3b). As expected, heat-inactivated
virus sharply reduced levels of viral RNA in cells. The re-
sults suggest that the RNA stem-loop structure altered by
Fig. 2 The stem-loop formed by nucleotide 142 to 170 in 5’UTR of HIV-1 genomic RNA is important for interaction with eEF1A. a The predicted
secondary structure of HIV-1 5’UTR is formed by TAR, polyA, tRNA anticodon-like element (TLE), PBS and stem-loop 1, 2, 3 (SL1, 2, 3). The arrows
indicate the sites of truncated RNA. b Biotin labelled wild-type, truncated and mutated 5’UTR RNAs were immobilized on biosensors. The
maximum responses (nm) during a 600 s incubation of each biosenor with 90 nM of eEF1A protein using OctetRed system are shown. c The local
secondary structures of wild-type, loop and bulge mutated RNAs and their minimum free energy (ΔG) were predicted using Mfold [21]. All data
sets are presented as mean ± SD from at least 3 independent experiments and * indicates p < 0.05
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Fig. 3 Bulge and loop mutations in 5’UTR of HIV-1 genomic RNA
resulted in reduced association of eEF1A and RT in virus infected
cells. a TZM-bl cells were infected with WT, Loop-M, Bulge-M virus
as indicated equal to 100 ng CAp24. Association of eEF1A with HIV-1
RTC in virus infected TZM-bl cells was determined by proximity
ligation assay using anti-eEF1A and anti-RT antibodies at 2 h of
post-infection. A red foci represents a positive signal that was
visualized using a DeltaVision Core imaging system and analysis was
performed from more than 200 cells. b The levels of genomic RNA
at 2 h of post-infection were determined by RT-PCR and possible
DNA contamination was examined by PCR without RT
Fig. 4 HIV-1 with bulge and loop mutations in 5’UTR of HIV-1
genomic RNA undergo reduced levels of reverse transcription and
replication in Jurkat cells. a Jurkat cells were infected with equivalent
amount of wild type, bulge and loop mutated HIV-1. Viral DNA was
extracted from cytoplasm at 4 h post-infection and analysed by
quantitative PCR measuring early and late reverse transcription DNA
products. b Virus replication was monitored for 14 days by measuring
CAp24 in culture supernatant at 3, 7 and 14 days post-infection. Data
are presented with mean ± SD of 3 independent experiments
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and RT.
The Bulge-M and Loop-M mutations in 5’UTR of HIV-1
genome affect late steps in HIV-1 reverse transcription
The effect of the Bulge-M and Loop-M mutations on re-
verse transcription and replication was examined by in-
fecting Jurkat cells with equivalent amount of either
wild-type or mutant viruses. The total cellular nucleic
acids was extracted from cytoplasm at 4 h of post-
infection followed by qPCR detection of the early (minus
strand strong-stop DNA, ssDNA) and late (2nd strand
transfer DNA) reverse transcription products. While the
levels of early DNA from the three virus stocks infectionwere similar (P > 0.05), the 5’UTR RNA mutations re-
sulted in a significant reduction in the amount of late
RT product detected (p < 0.05) (Fig. 4a). The levels of
late DNA from the Bulge-M and Loop-M mutated virus
infections dropped 3-4 fold compared with wild type
virus infection (Fig. 4a). Jurkat cells individually infected
with wild type or mutant viruses were monitored for
virus replication by measuring CAp24 in culture super-
natant for 2 weeks. Both mutant viruses showed a sig-
nificant reduction in replication kinetics compared to
wild type virus (Fig. 4b). The results indicate that the
structural changes in the RNA introduced by the two
mutations, which affect eEF1A binding to the RNA, lead
to reduced efficiency of reverse transcription as observed
by reduced levels of late DNA products compared to
Li et al. Virology Journal  (2015) 12:118 Page 7 of 10early DNA products. Hence, the mutations affect the
replication of HIV-1 in Jurkat cells.
Discussion
eEF1A was reported to have multiple roles in many virus
replications [1]. Here, we demonstrate, for the first time,
that eEF1A can bind to 5’UTR of HIV-1 genomic RNA,
which has functional roles in HIV-1 reverse transcrip-
tion and replication. A stem-loop structure, located at nt
142 to 170 of 5’UTR is important for the binding to
eEF1A as well as virus replication.
Recently, a TLE was identified in the HIV-1 5’UTR re-
gion of the genomic RNA, formed by nt 148 to160 [15],
which overlaps nt 142 to 170 identified in this study.
The TLE was shown to interact specifically with human
lysyl-tRNA synthetase (hLysRS) and the interaction is
important for the efficient annealing of tRNAlys3 to viral
RNA and virion packaging [15]. Both eEF1A and hLysRS
are able to bind tRNA or tRNA like structures, and both
are incorporated into HIV-1 virions [13, 22, 23]. As we
have demonstrated that eEF1 complex associates with
HIV-1 reverse transcription complex [12], it is very likely
that eEF1A interacts with genomic RNA during reverse
transcription. We showed that clustered mutations in
the 5’UTR result in structural changes in the 5’UTR of
HIV-1 RNA and reduce binding by eEF1A, which has
significant effect on the synthesis of late DNA but not
on early DNA products of reverse transcription. These
results suggest that while the bulge and loop mutation
interfered with association with eEF1A, they did not
affect annealing of tRNAlys3 to the viral genome because
infection of cells with equivalent amounts of wild type,
bulge or loop mutant HIV produced early viral DNA at
similar levels (Fig. 4). Our results here somewhat mirror
our previous study where downregulation of eEF1A by
siRNA-treatment in HIV-1 infected cells similarly re-
duced the late reverse transcription DNA synthesis [12].
Exactly how eEF1A affect late steps reverse transcription
through interaction with 5’UTR RNA is unclear. The re-
sults here suggest that eEF1A may engage the 5’UTR
RNA but subsequently interacts with the RTC by an al-
ternative and presently unknown mechanism.
As an RNA binding protein, eEF1A was reported to
bind to various RNA structures in many different RNA
viral genomes. The most extensively studied structures
are tRNA-like structures (TLS) identified at 3’end of
same virus genomic RNAs. For example, early investiga-
tions of bacteriophage RNA noted that cloverleaf-shaped
tRNA-like structures (TLSs) at the 3’end of RNA phage
Qβ binds with EF-Tu, the prokaryotic homolog of
eEF1A, to facilitate phage replication [24]. Subsequently,
eEF1A1 was shown to bind TLSs in the 3’UTRs of some
RNA plant viruses (reviewed in [25]) thereby affecting
translation of viral proteins, viral RNA synthesis andfacilitation of viral RNA encapsidation [26–28]. eEF1A
was also reported to bind to a RNA element referred to
as a “replication silencer” element (RSE) in the 3’UTR
RNA stem-loop structure of tomato bushy stunt virus
(TBSV) genomic RNA [3]. The RSE interaction with
eEF1A was shown to stimulate minus-strand RNA syn-
thesis [29]. eEF1A was shown to bind specifically to a
conserved stem-loop structure at 3’UTR of West Nile
virus (WNV) genomic RNA [30] to facilitate viral
minus-strand RNA synthesis [4].
eEF1A was also shown to bind RNA structures outside
the 3’UTR of viral genomes. Examples include the right
terminal stem-loop in hepatitis delta virus (HDV) gen-
omic RNA and an RNA cloverleaf structure at 5’end of
poliovirus genome [1]. The right terminal RNA stem-
loop domain of the HDV genome is a 199 nt RNA elem-
ent that contains a proposed initiation site for HDAg
mRNA transcription and negative-strand RNA synthesis
[31, 32]. The 5’-terminal 110 nt of the poliovirus RNA
genome can fold a secondary structure resembling a clo-
verleaf and functions to recruit the poliovirus proteinase
3CDpro. The interaction of eEF1A with the cloverleaf
structure may be necessary for virus replication [33, 34].
Our study demonstrates that eEF1A can bind to the
stem-loop structure in 5’UTR of HIV-1 genomic RNA,
and mutations in the RNA that disrupt the structure dis-
rupt association of eEF1A and RT leading to reduced
HIV-1 reverse transcription efficiency and virus replica-
tion. We propose that the HIV-1 5’UTR interaction with
eEF1A plays an important role in facilitating for eEF1A
function in reverse transcription. HIV genomic RNA is
highly structured throughout [17] and this study focuses
on the 5’UTR, whether eEF1A also binds to other parts of
the RNA for other roles remain for further investigation.
Conclusions
We conclude that the eEF1A-5’UTR RNA interaction is
important for efficient completion of HIV reverse tran-
scription. As eEF1A also binds to HIV Gag [13], RT [12]
and integrase [35] proteins, it is likely that eEF1A plays
multiple roles in HIV replication and the implications of
these roles warrant further investigation.
Materials and methods
Cell lines and virus culture
HEK293T and TZM-bl cell lines were grown in Dulbecco's
modified Eagle's medium supplemented with 10 % heat-
inactivated newborn bovine serum and 1× penicillin-
streptomycin. Jurkat cells were grown in RPMI 1640
supplemented with 10 % newborn bovine serum and
penicillin-streptomycin. All cell lines were incubated at
37 °C in 5 % CO2. A stock of wild type and mutated
HIV-1NL4.3 were generated by transfection of the cor-
responding proviral DNA using Lipofectamine 2000
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to the manufacturer's recommendations. Cell culture
supernatants were removed at 48 h posttransfection and
centrifuged (200 × g, 10 min), and the supernatant was
filtered (0.45 μm), treated with DNaseI and stored in 1-ml
aliquots at −80 °C.
Plasmid constructs
The pGCH infectious molecular clone is a HIV-1 pro-
viral plasmid which expresses authentic HIV-1 RNA
using the CMV immediate early promoter [36, 37]. The
shuttle contains a MluI (-604, containing the CMV pro-
moter) and SphI (+993) fragment from pGCH cloned
into pNEB193. Mutations were made using Quikchange
site-directed PCR mutagenesis as per manufacturer’s in-
structions (Stratagene) on the shuttle vectors and then
replaced back in the original backbone of pGCH. The
bulge structure mutation (Bulge-M) was made by chan-
ging CCC sequence at 142-144 nt to GGG and the top
loop region mutation (Loop-M) was generated by muta-
tion of CCC at 150-152 nt to GGG.
Biotin-labelled RNA transcription
DNA fragments contain a sp6 RNA promoter sequence
and HIV-1 5’UTR sequence or RT codoning sequence
were amplified by PCR using pGCH and its mutants as
template. The PCR products were purified and used as
template in the in vitro transcription reactions in the
presence of dUTP-biotin using a sp6 transcription kit
(Roche).
Reversible crosslink co-immunoprecipitation (CR-co-IP)
The experiment was performed as previously described
with modification [38] using either HIV-1 infection or
biotin-labelled RNA transfection. Briefly, TMZ-bl cells
were infected with HIV-1NL4.3 virus in the presence/ab-
sence of the HIV-1 RT inhibitor nevirapine at the final
concentration of 10 μM. To monitor for possible DNA
contamination from the virus stock, heat-inactivated
virus was used as a negative control. The virus was incu-
bated with cells for 2 h at 4 °C and 2 h at 37 °C and then
removed. Alternatively, cells were transfected with
biotin-labelled RNA and the cells were collected at 2 h
post-transfection. Next, the cells were washed three
times with PBS followed by crosslinking using 1 % for-
maldehyde in PBS for 10 min at room temperature,
which was stopped by adding 0.2 M glycine. The cells
were washed with PBS once and then lysed in hypotonic
buffer containing RNase-free DNaseI, RNase inhibitor
and proteinase inhibitors using Dounce homogenization.
The lysate was centrifuged at 16000 × g at 4 °C for
30 min and the supernatant was incubated with anti-
eEF1A antibody coated beads at 4 °C for 4 h followed by
three washes with PBS. The final immunoprecipitation(IP) product was resuspended in elution buffer (50 mM
Tris-HCl, PH 7.0, 5 mM EDTA, 10 mM DTT and 1 %
SDS) and heated for 45 min at 70 °C to reverse the
crosslinking. The RNA was extracted using Trizol re-
agent (Life Technologies, USA) according to the manu-
facturer’s protocol. HIV-1 RNA was detected by RT-PCR
targeting 5’UTR as described previously [39]. DNA con-
tamination was monitored by qPCR (omitting addition
of reverse transcriptase). To determine the levels of
biotin-labelled RNA, the RNA was loaded on the Hybond
membrane (Amersham Bioscience) followed by crosslink
using UV light for 3 min. The membrane was then
blocked using pierce protein free T20 blocking buffer
(Thermo Sciencfic, USA) and incubated with streptavidin-
peroxidase (Zeptometrix, USA) for 1 h at room
temperature and detected using clarity western ECL
substrate (Bio-Rad, USA).
Biolayer Interferometry (BLI) assay
BLI assay was performed as previous described with
some modifications [40] Biotin-labelled RNA was immo-
bilized onto streptavidin coated biosensors (Pall ForteBio,
CA, USA) by incubating the biosensors in 1 μM RNA so-
lution for 15 min with 800 rpm shaking in the OctetRed
system (Pall ForteBio, CA, USA). The association of RNA
with eEF1A protein (Origene Technologies, MD, USA)
was measured by incubating RNA biosensors in kinetic
buffer (1 mM phosphate, 15 mM NaCl, 0.002 % Tween-20
and 0.1 mg/ml BSA) containing various concentration of
eEF1A or eEF1G proteins (analyte) with 1000 rpm shaking
in the OctetRed system. The dissociation was determined
by moving the ligand biosensor from the analyte solution
to kinetic buffer.
Proximity ligation assays (PLA)
PLA assay was performed as previous described [12].
Briefly, TZM-bl cells were incubated with wild type or
mutant virus at 4 °C for 2 h to allow for virus attach-
ment. The cells were then incubated 2 h at 37 °C to ini-
tiate virus fusion, viral entry and reverse transcription.
The cells were fixed using 4 % paraformaldehye followed
by permeabilization by acetone. Duolink proximity
ligation assays were performed using a mouse monoclonal
antibody to detect HIV-1 RT in conjunction with rabbit
antibodies to eEF1A (Santa Cruz). DAPI stain was used
to visualize the nuclei. Cells were visualized using a
DeltaVision Core imaging system. Maximum-intensity
projections of deconvolved images were analyzed using
Duolink Image Tool software. More than 200 cells from
at least 20 fields were analyzed.
HIV-1 entry assay
TZM-bl cells were incubated with wild type or mutated
virus in the presence of nevirapine at 4 °C for 2 h and
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times and then collected using Trizol® reagent (Life
Technologies). The RNA fraction was column purified
using a Direct-zol mini-prep kit (Zymo Research) and
treated on the column with DNaseI prior to elution. The
purified RNAs were used in RT-PCR reactions in the
presence or absence of SuperScript® III reverse tran-
scriptase (Life Technologies) using random hexamer oli-
gonucleotides for the first strand DNA synthesis. qPCR
was performed as previously described [37].
CAp24 ELISA
CAp24 antigen in culture supernatant was measured by
using a RETROtek HIV-1 Cap24 antigen enzyme-linked
immunosorbent assay (ELISA) (Zeptometrix, USA) ac-
cording to the manufacturer's instructions.
RNA folding analysis
The RNA secondary structures were predicated using
online program (http://mfold.rna.albany.edu) with the
conditions, folding temperature of 37°, ionic conditions
of 1 M NaCl, no divalent ions; an upper bound number
of computed folding was 50; the maximum interior/
bulge loop size was 30.
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